Yangzhong Zhou

1.4k total citations
46 papers, 568 citations indexed

About

Yangzhong Zhou is a scholar working on Rheumatology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yangzhong Zhou has authored 46 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 9 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Yangzhong Zhou's work include Systemic Lupus Erythematosus Research (11 papers), Renal Diseases and Glomerulopathies (6 papers) and Zebrafish Biomedical Research Applications (6 papers). Yangzhong Zhou is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), Renal Diseases and Glomerulopathies (6 papers) and Zebrafish Biomedical Research Applications (6 papers). Yangzhong Zhou collaborates with scholars based in China, United States and United Kingdom. Yangzhong Zhou's co-authors include Qing Bai, Edward A. Burton, Clinton L. Cario, Jiaqi Liu, Zhihong Wu, Nan Wu, Xuemei Li, Wei‐Sheng Chen, Jia Chen and Gang Chen and has published in prestigious journals such as Cancer Cell, Nature Protocols and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yangzhong Zhou

42 papers receiving 556 citations

Peers

Countries citing papers authored by Yangzhong Zhou

Since Specialization

Citations

This map shows the geographic impact of Yangzhong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangzhong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangzhong Zhou more than expected).

Fields of papers citing papers by Yangzhong Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangzhong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangzhong Zhou. The network helps show where Yangzhong Zhou may publish in the future.

Co-authorship network of co-authors of Yangzhong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yangzhong Zhou. A scholar is included among the top collaborators of Yangzhong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangzhong Zhou. Yangzhong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort 2025 ·Lupus Science & Medicine ·(unknown), (unknown), Hui Jiang, Yangzhong Zhou, Liying Peng, Ziqian Wang, Junyan Qian, Wei Bai, Shangzhu Zhang, (unknown), (unknown), Xiaoxiao Guo, (unknown), Xiaofeng Zeng, (unknown), Yan Zhao	0
2	Systematic Review of the Outcomes and Prognostic Factors of Patients With Systemic Lupus Erythematosus-Associated Thrombotic Microangiopathy 2025 ·Kidney International Reports ·(unknown), (unknown), (unknown), Yangzhong Zhou, (unknown), Wei Bai, Jiuliang Zhao, (unknown)	0
3	Case report: Pulmonary artery hypertension secondary to SAPHO syndrome 2024 ·International Journal of Rheumatic Diseases ·(unknown), Junyan Qian, (unknown), Yangzhong Zhou, Shuang Zhou, Jiuliang Zhao, (unknown), Linyi Peng, Mengtao Li, Xiaofeng Zeng, Li Huo	1
4	The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV) 2024 ·Lupus ·(unknown), Yangzhong Zhou, Jiuliang Zhao, Chanyuan Wu, Shangzhu Zhang, Nan Jiang, Junyan Qian, Li Qin Zhang, Jing Li, Dong Xu, Xiaomei Leng, Qian Wang, Xinping Tian, Mengtao Li, (unknown)	0
5	Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Yangzhong Zhou, Bing Xu, (unknown), Jiuliang Zhao, Mengtao Li, Jiachen Xu, Guanqiao Li	5
6	Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis 2023 ·Arthritis & Rheumatology ·Xinping Tian, Mengtao Li, Nan Jiang, Yang Zhao, Jing Li, Yangzhong Zhou, Yahong Wang, Ying Wang, Taotao Li, (unknown), Yanhong Wang, Peter A. Merkel, Xiaofeng Zeng	17
7	Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort 2023 ·RMD Open ·(unknown), Can Huang, (unknown), Yangzhong Zhou, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng	2
8	Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China 2023 ·Lupus Science & Medicine ·Yangzhong Zhou, Chaojun Hu, (unknown), (unknown), Can Huang, Qian Wang, Xinping Tian, Jiuliang Zhao, (unknown), Xiaofeng Zeng	4
9	Adjuvant Concurrent Chemoradiotherapy vs. Radiotherapy Alone in Cervical Cancer Patients with Intermediate-Risk Factors after Radical Surgery 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Yangzhong Zhou, Ke Hu, (unknown)	1
10	Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome 2023 ·Rheumatology and Therapy ·(unknown), (unknown), Can Huang, Yangzhong Zhou, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Jiuliang Zhao	3
11	Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study 2023 ·Frontiers in Medicine ·(unknown), Liying Peng, Yangzhong Zhou, (unknown), Bin Zhao, (unknown), Xuemei Li	4
12	Cluster analysis of antiphospholipid antibodies-associated adverse pregnancy outcome patients: based on a 13-years cohort study 2023 ·Clinical and Experimental Medicine ·(unknown), Can Huang, Yixin Cui, (unknown), Yangzhong Zhou, Xiaohua Shi, Yijun Song, Xinping Tian, Mengtao Li, Juntao Liu, Xinyan Liu, Xiaofeng Zeng, Jiuliang Zhao	8
13	Next-generation liquid biopsy elucidates cfDNA origins from organ delineation to cellular population granularity 2023 ·Rongrong Chen, Jing Bai, Dake Zhang, (unknown), Yangzhong Zhou, (unknown), Ang Li, (unknown), (unknown), Steven J. Schrodi, Xin Yi	1
14	Association of Current Active Illnesses and Severe Acute Kidney Injury after COVID-19 Vaccines: A Real-World Study 2022 ·Vaccines ·Gang Chen, Qidong Ren, (unknown), Yangzhong Zhou, (unknown), Yining Wang, Xiaolin Li, (unknown), (unknown), Xuemei Li	2
15	Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis 2022 ·Experimental Hematology and Oncology ·(unknown), (unknown), Mingjie Luo, Kaini Shen, Yangzhong Zhou, Kaiyuan Guo, Yang Liu, Chen Yin, Yi Li, (unknown), Xiaohong Chen	19
16	Digitalized Adaptation of Oncology Trials during and after COVID-19 2020 ·Cancer Cell ·Guanqiao Li, Chen Yin, Yangzhong Zhou, Tongyan Wang, Jing Chen, Yang Liu, Ting Chen, (unknown), Linqi Zhang, Xiaohong Chen	13
17	Chronic Kidney Diseases and Acute Kidney Injury in Patients With COVID-19: Evidence From a Meta-Analysis 2020 ·Frontiers in Medicine ·Yangzhong Zhou, Qidong Ren, Gang Chen, Qiao Jin, (unknown), (unknown), Ke Zheng, Yan Qin, Xuemei Li	12
18	Quantitative Responses of Adult Zebrafish to Changes in Ambient Illumination 2017 ·Zebrafish ·(unknown), Qing Bai, Yangzhong Zhou, Edward A. Burton	9
19	CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling 2016 ·Human Genetics ·Jiaqi Liu, Yangzhong Zhou, Xiaolong Qi, Jia Chen, Wei‐Sheng Chen, Guixing Qiu, Zhihong Wu, Nan Wu	74
20	Wind power integration: From individual wind turbine to wind park as a power plant 2009 ·Data Archiving and Networked Services (DANS) ·Yangzhong Zhou	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact